Cognitive Decline and Its Risk Factors in Prevalent Hemodialysis Patients
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background Cognitive impairment is common in patients treated with hemodialysis. The trajectory of cognitive function and risk factors for cognitive decline remain uncertain in this population. Study Design Longitudinal cohort Setting & Participants Three hundred fourteen prevalent hemodialysis patients Predictors Age, sex, race, education level, hemodialysis vintage, cause of end-stage renal disease, and baseline history of cardiovascular disease (CVD). Outcomes Cognitive function as determined by a comprehensive neurocognitive battery, administered at baseline and yearly whenever possible. Individual cognitive test results were reduced into two domain scores using principal components analysis, representing memory and executive function, which were used as our co-primary outcomes, and by definition have a mean of zero and standard deviation of one. Results Mean age was 63 years; 54% were men, 22% were black and 90% had at least a high school education. During median follow up of 2.1 (IQR, 0.9–4.2) years, 196 had at least one follow up test, 156 died and 43 received a kidney transplant. Linear mixed models and joint models, which accounted for competing risks from death, dropout, or kidney transplantation, showed nearly identical results. The joint model demonstrated a decline in executive function (−0.09 [95% confidence interval, −0.13 to −0.05] SD per year), while memory improved slightly (0.05 [95% CI, 0.02 to 0.08] SD per year). A significant yearly decline was also seen in the Mini-Mental State Examination (median change of −0.41; 95% CI, −0.57 to −0.25). Older age was the only significant risk factor for steeper executive function decline (−0.04 [95% CI, −0.06 to −0.02] SD steeper annual decline for each 10 years of age). Limitations Prevalent hemodialysis patients only, limited follow up testing due to high mortality rate, and exclusion of participants with severe cognitive deficits or dementia Conclusions Prevalent hemodialysis patients demonstrate significant cognitive decline, particularly within tests of executive function. Older age was the only statistically significant risk factor for steeper cognitive decline, which may have important clinical consequences for patient management and education. Future studies should evaluate strategies to maintain or improve cognitive function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Memory and Executive Function in Aging and AD
Buckner, R. L. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.006 · Cited by 1,508
Cardiovascular risk factors and cognitive decline in middle-aged adults
Knopman, D., Boland, L. L., Mosley, T., Howard, G., Liao, D., Szklo, M., McGovern, P., & Folsom, A. R. (2001) · Neurology · doi:10.1212/wnl.56.1.42 · Cited by 883
Cognitive impairment in hemodialysis patients is common
Murray, A. M., Tupper, D. E., Knopman, D. S., Gilbertson, D. T., Pederson, S. L., Li, S., Smith, G. E., Hochhalter, A. K., Collins, A. J., & Kane, R. L. (2006) · Neurology · doi:10.1212/01.wnl.0000225182.15532.40 · Cited by 712
Levy (1994) · doi:10.1017/s1041610294001626 · Cited by 706
Johnston, S. C., O'Meara, E. S., Manolio, T. A., Lefkowitz, D., O'Leary, D. H., Goldstein, S., Carlson, M. C., Fried, L. P., & Longstreth, W. T. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-4-200402170-00005 · Cited by 304
O’Lone, E., Connors, M., Masson, P., Wu, S., Kelly, P. J., Gillespie, D., Parker, D., Whiteley, W., Strippoli, G. F. M., Palmer, S. C., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.12.028 · Cited by 266
Cited by
Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention
Drew, D. A., Weiner, D. E., & Sarnak, M. J. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.05.017 · Cited by 446
Self-citationMechanisms of cognitive dysfunction in CKD
Viggiano, D., Wagner, C. A., Martino, G., Nedergaard, M., Zoccali, C., Unwin, R., & Capasso, G. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0266-9 · Cited by 392
van Zwieten, A., Wong, G., Ruospo, M., Palmer, S. C., Barulli, M. R., Iurillo, A., Saglimbene, V., Natale, P., Gargano, L., Murgo, M., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx314 · Cited by 93
“Such work has already commenced [34, 35] and will be critical to the development of targeted prevention and treatment strategies.”
Backgroundβ2-microglobulin functions as an endogenous NMDAR antagonist to impair synaptic function
Gao, Y., Hong, Y., Huang, L., Zheng, S., Zhang, H., Wang, S., Yao, Y., Zhao, Y., Zhu, L., Xu, Q., et al. (2023) · Cell · doi:10.1016/j.cell.2023.01.021 · Cited by 75
Joint Models for Estimating Determinants of Cognitive Decline in the Presence of Survival Bias
Davis-Plourde, K. L., Mayeda, E. R., Lodi, S., Filshtein, T., Beiser, A., Gross, A. L., Seshadri, S., Glymour, M. M., & Tripodis, Y. (2022) · Epidemiology · doi:10.1097/ede.0000000000001472 · Cited by 15
Metadata
- Authors
- Drew, D. A., Weiner, D. E., Tighiouart, H., Duncan, S., Gupta, A., Scott, T., & Sarnak, M. J.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 69
- Issue
- 6
- Pages
- 780-787
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2580166460
- Cited by
- 119
- References
- 8
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.